Medication use during pregnancy is nearly universal, yet the evidence to guide safe use remains critically limited. Pregnant individuals have historically been excluded from randomised controlled trials, leaving them and their healthcare professionals (HCPs) to weigh the benefits and risks of pharmacological treatment on the basis of incomplete and slowly accruing post-marketing data. This evidence gap translates into therapeutic uncertainty, where both potentially harmful exposure and unjustifi